Postpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: Case report and review of the literature

Thrombosis Journal

Volumn 8, Issue , 2010, Pages

  Arampatzis, Spyridon ^a,b   Stefanidis, Ioannis ^b   Lakiopoulos, Vassilios ^b   Raio, Luigi ^c   Surbek, Daniel ^c   Mohaupt, Markus G ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF THESSALY   (Greece)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; CARDIOLIPIN ANTIBODY; CLOPIDOGREL; CREATINE KINASE; GLYCERYL TRINITRATE; HEPARIN; HYDROXYUREA; IMMUNOGLOBULIN M ANTIBODY; JANUS KINASE 2; METOPROLOL; SIMVASTATIN; TROPONIN T;

ADULT; ANGIOCARDIOGRAPHY; ANTIBODY TITER; ARTERY DISSECTION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CASE REPORT; CAUCASIAN; CESAREAN SECTION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ECHOCARDIOGRAPHY; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE SCANNER; PUERPERIUM; RECURRENT DISEASE; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 77953567602     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-8-12     Document Type: Article

References (33)

1. Bellucci S, Janvier M, Tobelem G, Flandrin G, Charpak Y, Berger R, Boiron M. Essential thrombocythemias. Clinical evolutionary and biological data. Cancer 1986, 58:2440-2447. 10.1002/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y, 3768838.
2. Tefferi A. The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview. Mayo Clin Proc 1998, 73:1177-1184. 10.4065/73.12.1177, 9868417.
3. Murphy S, Peterson P, Iland H, Laszlo J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997, 34:29-39.
4. Barbui T, Barosi G, Grossi A, Gugliotta L, Liberato LN, Marchetti M, Mazzucconi MG, Rodeghiero F, Tura S. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 2004, 89:215-232.
5. Passamonti F, Rumi E, Pungolino E, Malabarba L, Bertazzoni P, Valentini M, Orlandi E, Arcaini L, Brusamolino E, Pascutto C, et al. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. Am J Med 2004, 117:755-761. 10.1016/j.amjmed.2004.06.032, 15541325.
6. Mitus AJ, Barbui T, Shulman LN, Rosenthal DS, Viero P, Cortelazzo S, Schafer AI. Hemostatic complications in young patients with essential thrombocythemia. Am J Med 1990, 88:371-375. 10.1016/0002-9343(90)90491-U, 2327424.
7. Tefferi A, Fonseca R, Pereira DL, Hoagland HC. A long-term retrospective study of young women with essential thrombocythemia. Mayo Clin Proc 2001, 76:22-28. 10.4065/76.1.22, 11155408.
8. Randi ML, Rossi C, Fabris F, Girolami A. Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies. J Intern Med 1999, 246:517-518. 10.1046/j.1365-2796.1999.00614.x, 10583723.
9. Passamonti F, Randi ML, Rumi E, Pungolino E, Elena C, Pietra D, Scapin M, Arcaini L, Tezza F, Moratti R, et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation. Blood 2007, 110:485-489. 10.1182/blood-2007-01-071068, 17426257.
10. Beressi AH, Tefferi A, Silverstein MN, Petitt RM, Hoagland HC. Outcome analysis of 34 pregnancies in women with essential thrombocythemia. Arch Intern Med 1995, 155:1217-1222. 10.1001/archinte.155.11.1217, 7763128.
11. Greer IA. The challenge of thrombophilia in maternal-fetal medicine. N Engl J Med 2000, 342:424-425. 10.1056/NEJM200002103420610, 10666435.
12. Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, Johnson A, Osorio F, Goldberg C, Moore LG, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998, 54:2056-2063. 10.1046/j.1523-1755.1998.00217.x, 9853271.
13. Dorr HG, Heller A, Versmold HT, Sippell WG, Herrmann M, Bidlingmaier F, Knorr D. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J Clin Endocrinol Metab 1989, 68:863-868. 10.1210/jcem-68-5-863, 2715289.
14. James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006, 113:1564-1571. 10.1161/CIRCULATIONAHA.105.576751, 16534011.
15. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003, 24:761-781. 10.1016/S0195-668X(03)00098-8, 12800857.
16. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med 1996, 125:751-762.
17. Mather PJ, Hansen CL, Goldman B, Inniss S, Pina I, Norris R, Jeevanandam V, Bove AA. Postpartum multivessel coronary dissection. J Heart Lung Transplant 1994, 13:533-537.
18. Badui E, Enciso R. Acute myocardial infarction during pregnancy and puerperium: a review. Angiology 1996, 47:739-756. 10.1177/000331979604700801, 8712477.
19. Ladner HE, Danielsen B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol 2005, 105:480-484.
20. Rossi C, Randi ML, Zerbinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med 1998, 244:49-53. 10.1046/j.1365-2796.1998.00314.x, 9698024.
21. Watson KV, Key N. Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors. Br J Haematol 1993, 83:198-203. 10.1111/j.1365-2141.1993.tb08272.x, 8457467.
22. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol 2008, 52:171-180. 10.1016/j.jacc.2008.03.049, 18617065.
23. Harrison C. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. Br J Haematol 2005, 129:293-306. 10.1111/j.1365-2141.2005.05400.x, 15842653.
24. Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2005, 128:275-290. 10.1111/j.1365-2141.2004.05277.x, 15667529.
25. Wright CA, Tefferi A. A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol 2001, 66:152-159. 10.1034/j.1600-0609.2001.00367.x, 11350483.
26. Barbui T, Finazzi G. When and how to treat essential thrombocythemia. N Engl J Med 2005, 353:85-86. 10.1056/NEJMe058093, 16000360.
27. Delage R, Demers C, Cantin G, Roy J. Treatment of essential thrombocythemia during pregnancy with interferon-alpha. Obstet Gynecol 1996, 87:814-817.
28. Weissman A, Coplan NL. Antiphospholipid antibody syndrome and acute stent thrombosis. Rev Cardiovasc Med 2006, 7:244-246.
29. Kaplan SD, Chartash EK, Pizzarello RA, Furie RA. Cardiac manifestations of the antiphospholipid syndrome. Am Heart J 1992, 124:1331-1338. 10.1016/0002-8703(92)90420-Z, 1442504.
30. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, Tolosa C, Franz J, Selva A, Ingelmo M, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 1994, 96:3-9. 10.1016/0002-9343(94)90108-2, 8304360.
31. Miller D, Waters DD, Warnica W, Szlachcic J, Kreeft J, Theroux P. Is variant angina the coronary manifestation of a generalized vasospastic disorder?. N Engl J Med 1981, 304:763-766.
32. Harrison CN, Donohoe S, Carr P, Dave M, Mackie I, Machin SJ. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Thromb Haemost 2002, 87:802-807.
33. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999, 340:9-13. 10.1056/NEJM199901073400102, 9878639.